Post-TRaUmatic STress Disorder Induced by Gynecological Brachytherapy
- Conditions
- Uterine Cervical Neoplasms
- Registration Number
- NCT07204535
- Lead Sponsor
- Centre Paul Strauss
- Brief Summary
This is a multicenter, prospective study aimed at providing information on the psychological effects (including post-traumatic stress symptoms) of utero-vaginal brachytherapy in patients with cervical cancer using self-administered questionnaires. The study also aims to assess the persistence of these symptoms over time, up to 5 years after brachytherapy. The results could help identify patients at risk of post-traumatic stress in this context and develop appropriate psychological interventions to improve their psychological well-being during and after treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Female
- Target Recruitment
- 80
- Confirmed diagnosis of cervical cancer with an indication for High-dose rate (HDR) or pulse-dose rate (PDR) uterovaginal brachytherapy;
- Squamous cell carcinoma or other histological types;
- WHO ≤ 2;
- Ability to complete validated questionnaires in French;
- Informed consent to participate in the study;
- Patients over 18 years old
- Inability to understand or respond to questionnaires due to a cognitive disorder, intellectual disability, language barrier, or psychiatric disorder that impairs judgment;
- Patient under juridic protection;
- Pregnant or breastfeeding woman
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Post-Traumatic Stress Disorder evaluation at 2 months Evaluation with post-traumatic stress disorder Checklist version DSM-5 (PCL-5) - questionnaire with a Cut off score ≥ 32
- Secondary Outcome Measures
Name Time Method Anxiety and Depression until 60 months Hospital Anxiety and Depression scale
Quality of Life (general module) until 60 months Evaluated with EORTC QLQ-C30 questionnaire
Quality of Life (cervical cancer module) until 60 months Evaluated with EORTC QLQ-CX24 questionnaire
Sexual Health evaluation until 60 months Sexual Health Questionnaire (EORTC SHQ-22)
Trial Locations
- Locations (1)
ICANS
🇫🇷Strasbourg, France
ICANS🇫🇷Strasbourg, FranceGeorge NOEL, MD, PhDContact368766767promotion-rc@icans.eu